跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Trimetazidine Dihydrochloride Sustained-release Tablets
Approved
化学药品
Trimetazidine Dihydrochloride Sustained-release Tablets
石家庄市华新药业有限责任公司
🇨🇳 National Medical Products Administration
Approval Date
May 22, 2023
Approval ID
467a12e1d9571252
Company
石家庄市华新药业有限责任公司
Type
化学药品
Approval Details
Approval Id
467a12e1d9571252
Approval Number
国药准字H20223951
Generic Name
盐酸曲美他嗪缓释片
Generic Name En
Trimetazidine Dihydrochloride Sustained-release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
35mg
Reg Date
2023-05-22
Company Name
石家庄市华新药业有限责任公司
Company Address
灵寿县南环东路(城东工业园区)
Production Company Name
石家庄市华新药业有限责任公司
Production Company Address
石家庄市灵寿县南环东路(城东工业园区)
Company Detail Path
/organization/shi-jia-zhuang-shi-hua-xin-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path
/organization/shi-jia-zhuang-shi-hua-xin-yao-ye-you-xian-ze-ren-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 22, 2023
Approval ID
467a12e1d9571252
Type
化学药品
Back to NMPA Approvals
盐酸曲美他嗪缓释片 - NMPA Drug Approval Details